Achievement of surface antigen clearance in the liver by combination therapy with REP 2139-Ca and nucleoside analogues against chronic hepatitis B - Quinet, J; Jamard, C; Vaillant, A; Cova, L
International Liver Congress; Barcelona, Spain; April 12–17, 2016. THU-177